Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-12-20 4:32 pm Sale | 13G | UNICYCIVE THERAPEUTICS INC UNCY | Nantahala Capital Management LLC | 0 0.000% | -3,475,713 (Position Closed) | View |
| 2024-12-20 4:31 pm Sale | 13G | UNICYCIVE THERAPEUTICS INC UNCY | Nantahala Capital Partners Limited Partnership | 0 0.000% | -2,121,753 (Position Closed) | View |
| 2024-11-14 7:13 pm Purchase | 13G | UNICYCIVE THERAPEUTICS INC UNCY | Logos Global Management LP | 5,078,927 4.900% | 1,609,000 (+46.37%) | View |
| 2024-11-14 7:01 pm Purchase | 13G | UNICYCIVE THERAPEUTICS INC UNCY | Vivo Opportunity Fund Holdings L.P. | 60,961,729 9.990% | 1,000,000 (+1.67%) | View |
| 2024-11-14 5:46 pm Purchase | 13G | UNICYCIVE THERAPEUTICS INC UNCY | RA CAPITAL MANAGEMENT L.P. | 10,472,375 9.990% | 7,000,269 (+201.61%) | View |
| 2024-11-14 5:05 pm Purchase | 13G | UNICYCIVE THERAPEUTICS INC UNCY | GREAT POINT PARTNERS LLC | 9,522,432 9.990% | 963,432 (+11.26%) | View |
| 2024-11-14 4:29 pm Purchase | 13G | UNICYCIVE THERAPEUTICS INC UNCY | BIOTECHNOLOGY VALUE FUND L P | 10,471,230 9.990% | 7,001,005 (+201.74%) | View |
| 2024-11-13 4:52 pm Purchase | 13G | UNICYCIVE THERAPEUTICS INC UNCY | Walleye Capital LLC | 5,000,000 5.300% | 5,000,000 (New Position) | View |
| 2024-10-11 4:02 pm Purchase | 13G | UNICYCIVE THERAPEUTICS INC UNCY | Octagon Capital Advisors LP | 8,559,000 9.100% | 8,559,000 (New Position) | View |
| 2024-07-18 4:10 pm Purchase | 13G | UNICYCIVE THERAPEUTICS INC UNCY | GREAT POINT PARTNERS LLC | 8,559,000 9.990% | 8,559,000 (New Position) | View |
| 2024-02-14 6:41 pm Purchase | 13G | UNICYCIVE THERAPEUTICS INC UNCY | RA CAPITAL MANAGEMENT L.P. | 3,472,106 9.990% | 1,417 (+0.04%) | View |
| 2024-02-14 4:51 pm Purchase | 13G | UNICYCIVE THERAPEUTICS INC UNCY | Nantahala Capital Management LLC | 3,475,713 9.900% | 2,268,297 (+187.86%) | View |
| 2024-02-14 3:18 pm Unchanged | 13G | UNICYCIVE THERAPEUTICS INC UNCY | ARMISTICE CAPITAL LLC | 976,000 2.730% | 0 (Unchanged) | View |
| 2024-02-02 8:32 pm Purchase | 13G | UNICYCIVE THERAPEUTICS INC UNCY | Nantahala Capital Partners Limited Partnership | 2,121,753 6.100% | 2,121,753 (New Position) | View |
| 2024-01-22 4:27 pm Purchase | 13G | UNICYCIVE THERAPEUTICS INC UNCY | Logos Global Management LP | 3,469,927 9.900% | 3,469,927 (New Position) | View |
| 2023-07-14 4:30 pm Purchase | 13G | UNICYCIVE THERAPEUTICS INC UNCY | Vivo Opportunity Fund Holdings L.P. | 59,961,729 9.990% | 59,961,729 (New Position) | View |
| 2023-07-06 5:23 pm Purchase | 13G | UNICYCIVE THERAPEUTICS INC UNCY | BIOTECHNOLOGY VALUE FUND L P | 3,470,225 9.990% | 3,470,225 (New Position) | View |
| 2023-07-06 4:30 pm Purchase | 13G | UNICYCIVE THERAPEUTICS INC UNCY | RA CAPITAL MANAGEMENT L.P. | 3,470,689 9.990% | 3,470,689 (New Position) | View |
| 2023-02-14 4:52 pm Sale | 13G | UNICYCIVE THERAPEUTICS INC UNCY | Nantahala Capital Management LLC | 1,207,416 8.000% | -39,340 (-3.16%) | View |
| 2023-02-14 1:41 pm Purchase | 13G | UNICYCIVE THERAPEUTICS INC UNCY | ARMISTICE CAPITAL LLC | 976,000 6.080% | 176,000 (+22.00%) | View |